Quick Facts
FONT-SIZE Plus   Neg
Share SHARE

Bruker Acquires SkyScan For Undisclosed Terms - Quick Facts

Bruker Corp. (BRKR: Quote) Monday said it has acquired all shares of SkyScan N.V., a scientific instruments company located near Antwerp, Belgium. Financial details were not disclosed.

SkyScan develops, manufactures and distributes advanced, high-resolution micro computed tomography systems for three-dimensional X-ray imaging.

The company derives around 50 percent of its revenue from materials science and the remaining 50 percent from life science and preclinical imaging applications.

The acquisition is expected to add around $13 million to Bruker's revenue in the remainder for 2012. The deal is estimated to be accretive to earnings per share by about $0.01.

Following the acquisition, SkyScan has been renamed Bruker microCT N.V., and will continue to operate from the company-owned premises in Belgium under its previous management.

The new Bruker microCT business will continue to produce all micro-CT instruments under the SkyScan brand, and will provide enhanced global support for the installed worldwide base of SkyScan.

Frank Laukien, President and CEO of Bruker, said, "We are impressed by the portfolio of high-performance SkyScan products which fit nicely into our global materials research and preclinical imaging distribution channels, and which complement our other X-ray analysis and preclinical MRI products."

Register
To receive FREE breaking news email alerts for Bruker Corporation and others in your portfolio

by RTT Staff Writer

For comments and feedback: editorial@rttnews.com

Business News

Quick Facts

Editors Pick
Toyota Motor Corp. (TM, TYT.L) Thursday announced 1.1 percent decline in worldwide production for October, as there was a sharp decline in production of passenger cars in Japan. Production outside Japan improved 2.3 percent. In a separate announcement, the Japanese automaker said it will recall more... Computer and printer maker Hewlett-Packard Co. said Tuesday after the markets closed that its fourth quarter profit fell 6% from last year, as revenue declined 2%. The company's quarterly earnings per share, excluding items, came in line with analysts' expectations, but its quarterly revenue fell short of analysts' forecast. This organic and natural products company has experienced strong compounded annual growth over the last four fiscal years with its net sales growing 25% and adjusted income from continuing operations over 30%.
comments powered by Disqus
FREE Newsletters, Analysis & Alerts

 

Stay informed with our FREE daily Newsletters and real-time breaking News Alerts. Sign up to receive the latest information on business news, health, technology, biotech, market analysis, currency trading and more.